Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Ted Borgel named VP-quality & compliance, private labeler announces Feb. 7. Borgel will be responsible "for all quality assurance and regulatory compliance functions and will serve as a member of the Corporate Planning Team," firm says. Borgel brings more than 35 years of experience in senior management roles at companies such as Eli Lilly, Alcon Labs and Bausch & Lomb and faces the challenge of cleaning up Perrigo's quality control program following unfavorable FDA inspection of firm's Allegan, Mich. facility in August (1"The Tan Sheet" Sept. 11, 2000, p. 13)
You may also be interested in...
Perrigo Extended-Release Acetaminophen Launch Delayed By QC Issues
Perrigo has postponed its plans to market private label extended-release acetaminophen until it can resolve quality control issues outlined in a recent FDA warning letter.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands